chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Mild fever; fatigue; Soreness of arm; Muscle ache; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Mild fever), FATIGUE (fatigue), VACCINATION SITE PAIN (Soreness of arm) and MYALGIA (Muscle ache) in an 84-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, the patient experienced PYREXIA (Mild fever), FATIGUE (fatigue), VACCINATION SITE PAIN (Soreness of arm) and MYALGIA (Muscle ache). At the time of the report, PYREXIA (Mild fever), FATIGUE (fatigue), VACCINATION SITE PAIN (Soreness of arm) and MYALGIA (Muscle ache) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In October 2020, COVID-19: positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment details included Advil.   Most recent FOLLOW-UP information incorporated above includes: On 28-Apr-2021: addt'l info  NNI.  Incorrect gender details in follow-up.
Information has been received from a nurse practitioner concerning a female patient with no medical history who on 26-JUN-2007 was vaccinated into the left deltoid with a first dose of Gardasil vaccine (Lot# 658558/1060U). After the vaccination, the patient fainted. It was reported that it lasted a few seconds and her vital signs wre stable. Unspecified medical attention was sought. No laboratory diagnostic studies wer performed. On an unknown date, the patient recovered. No product quality complaint was involved. Additional information has been requested. This is in follow-up to report (s) previously submitted oon 11/14/2007. It was also reported that the patient received a 2nd dose of GARDASIL vaccine with no adverse events. Additional information is not expected
Adverse/Allergic reaction (hives); Allergic reaction/ allergy; This case was reported by a consumer via other manufacturer and described the occurrence of hives in a 65-year-old female patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced hives and allergic reaction. On an unknown date, the outcome of the hives and allergic reaction were unknown.   It was unknown if the reporter considered the hives and allergic reaction to be related to Shingles vaccine.  Additional details were provided as follows: The age at vaccination was not reported.  After receiving dose of Shingles vaccine, the patient experienced allergic reaction or allergy like hives. The reporter consent to follow up.
This is a spontaneous report received from a consumer or other non-HCP (patient). A 46-year-old male patient received unknown dose number of BNT162B2 (Comirnaty, batch/lot# unknown), single dose, for COVID-19 immunisation. The patient's medical history and concomitant medications not reported. The patient had fatigue and headache, with outcome of unknown. No follow-up attempts possible. Information about batch/lot number cannot be obtained. No further information expected.
A day after she got vaccination, she noticed rashes down her left arm. A few days later she noticed that she had dysphagia, became weaker and more tired and she felt as though her throat was closing off. She went to the ER on 3/8/21 and she was given Benadryl, Prednisone and Pepcid and sent home. SHe had also been given Rx for Epi pen, and Prednisone . She subsequently had chest pain, significant dyspnea, the sensation that her throat will close off, joint pain and a sensation of lung constriction. She came to see me with these symptoms on 3/11/21. I Sent her to the ER again and she was given solumedrol, IV Benadryl & epinephrine by EMS en route. At the ER, her D dimer, chest X ray, troponins and EKG were unremarkable. GFR was decreased at 48 at that time with mildly low K of 3.4. She was given Ativan, and oxygen and she was discharged. She continued to have dyspnea, chest pain, and fatigue. She was experiencing nausea as well. She was prescribed Asmanex and refered to pulmonology. Repeat labs were mostly unremarkable with normalization of GFR and K. Her dyspnea,chest pain, nausea, rash, muscle & joint pain and sensation of throat closing off, resolved by the end of March. Fatigue also improved.
The provider sent in a prescription to Pharmacy on 6/13/2023 for a Shingrix series.  The dose was administered with no issues.  Upon entering the vaccination details into vaccination database, I discovered that the patient has already received a complete series (1st dose 10/13/2020 & 2nd dose 01/07/2021) making this dose her 3rd.   Generally, we double check the database before administration, but this was missed since provider sent in the request.
hard to move around; she feels weak; she felt the exhaustion was progressively worse and that she had some chills; she felt her arm being sore; a little bit of tiredness/she felt the exhaustion was progressively worse and that she had some chills; This is a spontaneous report from a contactable consumer or other non hcp (patient). A 49-years-old female patient received bnt162b2 (BNT162B2, solution for injection), dose 1 via an unspecified route of administration on 22Jun2021 09:00 (Batch/Lot number was not reported) as DOSE 1, SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. 49-year-old, Female patient reported that post vaccination of her first dose of the PFIZER-BIONTECH COVID-19 VACCINE on Tuesday (22Jun2021) at 9 AM, she felt her arm being sore and a little bit of tiredness. However, 4 days after, she felt the exhaustion was progressively worse and that she had some chills. In line with this, patient would like to know if it was common for side effects to start a few days after the vaccines. As she had read that side effects are commonly occurring within 1-2 days and was resolved thereafter. The clinical outcome of the event was fatigue was not recovered, remaining all other events was unknown at the time of report. Follow-up actions are needed. Further information has been requested.  The lot number for the vaccine, [PFIZER-BIONTECH COVID-19 VACCINE], was not provided and will be requested during follow up.
This spontaneous report was received from a consumer (patient's mother) regarding a 5 year old male patient. The patient's medical history included low grade fever. Patient's historical drugs included PENTACEL. Patient's concomitant medication included acetaminophen. Patient did not have any pertinent medical history. On 09-APR-2018, the patient was vaccinated with VARIVAX, (strength, dose, frequency, lot number and expiry date not reported), intramuscularly in the upper right deltoid (incorrect route of administration), for prophylaxis. On the same day around 15:30 (shortly after receiving the vaccination), the patient experienced pain and stiffness in the arm. On the same day, he received acetaminophen as a treatment for the event. On 10-APR-2018, morning, patient's arm was extremely swollen (further described as "hard, hot, twice the size as normal"). The patient was treated with ice packs and with unknown amount of acetaminophen as per doctor's instructions. On 12-APR-2018, the patient injection site was "cellulitis looking" (further described as "now it has divets around the upper right arm and it's still swollen"). The patient sought medical attention but was not hospitalized for the events. Lab diagnostics/studies were not performed. Outcome of the events was reported as not recovered. A causality assessment was not provided. A product quality complaint (PQC) was not filed. Upon internal review, the event of cellulitis was considered as medically significant. This is one of two reports from the same reporter.
feeling very tired (within 25 min), headache (within 3 hrs) worsened over the next several hours, muscle aches (within 8 hrs) worsened in time, fever (@100 dgs) with chills (within 8hrs), runny nose, watery eyes and dry mouth (within 8hrs), sinus pain (dry) and loss of appetite Called advice line @ 7am on 3/7/21 to see if I could take Ibuprophen (yes) and that helped. All side effects subsided in @ 36 hours.
mom states child had sz type activity x 6 1 day p/vax;hosp x 4 days states MRI shows some abn areas;MRI post sx acitvity;
Sunday night Feb 22 I experienced a lot of itching around injection site area. I iced area by Feb 23 area was inflamed, rough, red, and very itchy .. it began to widen and spread out. Tuesday Feb 24 area was very red and spread out, I called my doctor and was prescribed antibiotics to treat a possible case of cellulitis. I continued to apply hydrocortisone on the area and by weds it seemed to have gotten better. Thursday feb 24 .. the area spread further down my arm and is now blotchy and very itchy but only on the outer area. Today the area is inflamed and still very big and spreading.  Very itchy .. I called the pharmacy to report the events and began taking the antibiotics today. I have not seen any improvement at this point and am hoping this goes away soon.
Pt got lightheaded just a few minutes after receiving the vaccination. Pt has had this reaction to immunizations & blood draws in the past.
12/06/2006 Seen by us 12/5/06 after rash for 2 days. No fever. Few chicken pox lesions on trunk and rest of body. (20). No fever. Child treated with Atarax.
Day after vacc. fist size mark showed up at inj. site. Site is hard, hot, lump. Pt doesn't have fever or dyspnea. Mom gave pt BENADRYL. TYLENOL also recommended.
"Pt c/o severe dizziness at approximately 3:36PM. Received 1st dose MODERNA at 3:25PM. Pt was found laying on the floor, present with his spouse. Pt stated that he wanted to lay flat and brought himself to the floor. Pt was then transferred via W/C to triage area.   Pt stated that he was experiencing dizziness, was placed on recliner chair. Offered and provided water. Pt denied experiencing any other abnormal symptoms. Per pt, has hx of vasovagal symptoms. On-site lead notified, NP notified.   V/S taken: @3:30PM - BP - 109/66, HR - 65, RR - 18   Np provided further eval. Pt monitored for add'l 15 min, given OK to be released from clinic.   V/S taken: @347PM - BP - 114/76, HR - 76   Pt verbalized improvement to sxs, stated OK to leave. ED precautions provided. Pt left, stable gait, accompanied by spouse. "
I would say the day after mild injection site pain, then at 10 days after mild fatigue and at 14 days after a migraine.
Wrong Vaccine administered. Pt had made an appointment for a Pfizer booster vaccine and received a Moderna booster vaccine in error.
Warm, red, itchy area local to injection site, advised to watch carefully, take BENADRYL. I will call pt to follow up tomorrow.
I have had chronic, progressive pain in my left shoulder after receiving the influenza vaccination. The injection site felt high on my shoulder the day I received it and I have had chronic pain from the site radiating down my arm, as well as to my neck and upper back ever since. I also experience sharp pains during left arm abduction and front raise movements as well as headaches. I work at a hospital and the nurse I work with got the vaccine as well. We both felt that the injection was far too high. The pain and movement restrictions are progressively increasing as well as the headaches and it has greatly inhibited my sleeping.
Hypotensive event that required emergency room visit 12 hours after vaccine. Patient administered fluids and reported systolic BP of 60. Patient has recovered with current BP readings of about 100/60.
Two times was after I took the shingles vaccine/suspected vaccination failure; One busted in my eye; shingles; horrible pain; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   The patient's past medical history included shingles (had shingles 4 times before vaccination).   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), ophthalmic herpes zoster (serious criteria GSK medically significant), shingles and pain. On an unknown date, the outcome of the vaccination failure, ophthalmic herpes zoster, shingles and pain were unknown.   It was unknown if the reporter considered the vaccination failure, ophthalmic herpes zoster, shingles and pain to be related to Shingles vaccine.     Additional Information: GSK receipt date: 2-June-2022 Reporter's comment: This case was reported by a patient via interactive digital media. The patient had shingles 6 times. Two times had shingles after the shingles vaccine. The patient was in horrible pain. One busted in patient's eye. Additional Supportive Information: This case was considered as suspected vaccination failure since the details regarding completion of primary vaccination schedule, time to onset and laboratory confirmation of shingles was not provided.
Lymph nodes under arms were very sore; This is a spontaneous report from a non-contactable consumer, the patient. A 55-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: 0151) via an unspecified route of administration on 05Apr2021 (at the age of 55-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19 on an unknown date. Concomitant medications included vitamin D (MANUFACTURER UNKNOWN), febuxostat (MANUFACTURER UNKNOWN), pantoprazole (MANUFACTURER UNKNOWN) and gabapentin (MANUFACTURER UNKNOWN), all taken from unknown dates for unspecified indications. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 06Apr2021, the patient experienced very sore lymph nodes under arms. The event did not result in a visit to the doctors or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the event very sore lymph nodes under arms was resolved on an unknown date in 2021.  No follow-up attempts are possible. No further information is expected.
The guardian filling out the vaccine consent form with a date of birth of not exact to meet the criteria for the Pfizer Covid19 immunization.  The form was signed by the mother.   I tried to reach the mom of the patient on 08/27/2021 to confirm the date of birth.  I left a message to call me back at the pharmacy.  I was able to reach the mom on 08/30/2021.  Mom informed me that the wrong date of birth was on the form and that she must have mistakenly put it in for a sibling of the patient.  The actual date of birth is exact.   There were no reported adverse effects of  the vaccine.  I also informed the mom that under current guidelines that I was not able to provide the second shot to the patient since he did not meet the age requirements.
temperature excursions; No adverse event; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (temperature excursions) and NO ADVERSE EVENT (No adverse event) in an adolescent patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AR9236B) for COVID-19 prophylaxis.     No Medical History information was reported.    On 15-Nov-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (temperature excursions) and NO ADVERSE EVENT (No adverse event). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (temperature excursions) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for PRODUCT TEMPERATURE EXCURSION ISSUE (temperature excursions).    Concomitant medications were not reported.  The 5 patients were administered with the Moderna Covid 19 vaccine after these vaccines had surfer multiple temperature excursions. The case is for the 5th patient out of 5 patients. Treatment medications were not reported.
Additional information provided patient demographics, product details, laboratory tests and event details. Information regarding PREVNAR was received from a healthcare professional regarding an 18-month-old male patient who experienced fever, shaky, crying, not eating all day and awake all night. The patient received the fourth dose on 16-Dec-2009. On 17-Dec-2009, the patient experienced fever progressing to 104.4 degrees Fahrenheit, was shaky, crying and not eating all day. Treatment included TYLENOL but temperature remained elevated. On 18-Dec-2009, the patient was examined by the physician at the office and the patient's ears and throat were reported as "clear". Later that day the fever abated (99.7 degrees Fahrenheit,). The patient was reported to have been awake all night and crying. A urine specimen was collected, but no results were reported. On 19-Dec-2009, the events resolved and the patient was reported as "fine" and back to his "old self". No additional information was available at the time of this report.
pt recvd Hep B vax on 18MAY92 & approx 48 hrs following vax devel blotchy urticarial rash over arms & trunk of body;
had two blood clots on her lungs; This is a spontaneous report from a contactable consumer. A 20-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), first dose at the age of 20-years-old via an unspecified route of administration, administered in arm left on 28Mar2021 12:30 (Batch/Lot Number: ER8730) as single dose for covid-19 immunisation.  Medical history included birth control from an unknown date and unknown if ongoing. Concomitant medication included ethinylestradiol, norgestimate (SPRINTEC) taken for birth control from Dec2020 to 12Apr2021. The patient experienced had two blood clots on her lungs on 12Apr2021 18:00.  The patient was hospitalized due to the event from 12Apr2021 to 14Apr2021. The patient was recovering from the event.
I've already once reported extreme anxiety being experience immediately following receiving this vendors vaccine.   And it is still occurring.    I wanted to expound on other issue which have begun/grown in severity since receiving Covid Vaccines and have begun to negatively affect what was normal life.    Difficulties performing my job due to memory and comprehension issues.    I find myself now forgetting my zip code, phone number, mailbox combination  as well as other simple things that generally require no thought-- this year has gotten bad.    In addition I struggle to comprehend even mid-level complex technologies now.... I work in.    I worry about not meeting  job requirements due to fairly recent cognitive impairments since getting the covid shots.    Further extreme exhaustion and depression have rooted themselves into my life in addition to anxiety.    I took anti-anxiety meds for awhile and while they helped -- side-effects such as exhaustion only got worse.   I am now on anti-depressant as well.     Neither of these terrible afflictions I had prior to the covid vaccinations.     I worry constantly about whether this is as severe as all I mention will become or only the start.    I worry about employment if at times I struggle to remember even simple things.
10/10 - extreme body ache/joint paint/fever/diarrhea/vomiting/loss of appetite/headache/dizziness. These symptoms lasted through 10/14. On 10/15, I broke out in a full body rash that covered everything except for the palms of my hands and soles of my feet.
Vaccine brand: Pfizer/BioNTech, vaccine dose number: 2/ Vaccine brand: Moderna Booster, vaccine dose number: 3; COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 44-year-old female patient (not pregnant) received bnt162b2 (BNT162B2), on 05Mar2021 as dose 1, single (Batch/Lot number: unknown), in left arm and on 26Mar2021 as dose 2, single (Batch/Lot number: unknown) at the age of 41 years, in left arm for covid-19 immunisation; davesomeran, elasomeran (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)), on 03Dec2021 as dose 3 (booster), single (Batch/Lot number: unknown), in left arm and on 13Sep2022 as dose 4 (booster), single (Batch/Lot number: unknown), in left arm for covid-19 immunisation. The patient's relevant medical history included: "Migraine" (unspecified if ongoing); "narcolepsy" (unspecified if ongoing); "known allergies: Shell fish" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Sep2023, outcome "unknown" and all described as "COVID 19 Treatment"; INTERCHANGE OF VACCINE PRODUCTS (medically significant), outcome "unknown", described as "Vaccine brand: Pfizer/BioNTech, vaccine dose number: 2/ Vaccine brand: Moderna Booster, vaccine dose number: 3". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive. Therapeutic measures were taken as a result of drug ineffective, covid-19 with Paxlovid from 23Sep2023 to 28Sep2023.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202300321178 Same patient, different drug, different event;
Terrible itching - like I was bitten by a 100 mosquitos. It felt hot to feel it; very red and very itchy. It was very swollen. Made my arm felt tight but not unbearable. It took a week to go away - it was the same every day. I tried to use Hydrocortisone cream  - a fresh tube of it - it did help alleviate the itching - some of it for awhile but the itch would fire back up again. After a shower, it got really red. It was resolved before the other vaccine.